NCT00002579View on ClinicalTrials.gov

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

March 31, 1993

Conditions

Breast Cancer

Interventions

DRUG

CMF regimen

DRUG

cyclophosphamide

DRUG

fluorouracil

DRUG

methotrexate

DRUG

tamoxifen citrate

PROCEDURE

conventional surgery

RADIATION

radiation therapy

Trial Locations (10)

LE1 5WW

Leicester Royal Infirmary NHS Trust, Leicester

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

DD1 9SY

Ninewells Hospital and Medical School, Dundee

EH4 9NQ

Western General Hospital, Edinburgh

G11 6NT

Beatson Oncology Centre, Glasgow

G61 1BD

University of Glasgow, Glasgow

1V2 3UJ

Raigmore Hospital, Inverness

Unknown

Royal Alexandra Hospital, Paisley

KA6 6DX

Ayr Hospital, Ayr

FK1 5RE

Falkirk Royal Infirmary, Falkirk

All Listed Sponsors

lead

Scottish Cancer Therapy Network

OTHER

NCT00002579 - Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | Biotech Hunter | Biotech Hunter